Specialty Pharmaceuticals Businesses for Sale in Dewas

The company is a certified pharmaceutical formulations manufacturing company, specializing in tablets, capsules (soft and hard gelatin), liquid orals (syrups), and ointments. - Our primary business model is B2B, supplying to 50 stockists and 30 retailers. - The company holds multiple certifications and regulatory approvals, including WHO GMP (Good Manufacturing Practices), ISO 9001:2015 – Quality Management System, FSSAI (Food Safety and Standards Authority of India), CDSCO (Central Drugs Standard Control Organization), Ayush license, and State FDA approval. - Production capacity and utilization: 1) Tablets: Installed capacity – 1.03 crore units; current utilization – 30 to 80 lakh units. 2) Soft gelatin capsules: Installed capacity – 25 lakh units; utilization – 25 lakh units. 3) Hard gelatin capsules: Installed capacity – 15 lakh units; utilization – 9 lakh units. 4) Syrups (liquid orals): Installed capacity – 75,000 units; utilization – 13,000 units. 5) Ointments: Installed capacity – 5,000 tubes; utilization – 3,000 tubes. - Sales have significantly increased this year due to a strategic shift from generic drugs to ethical marketing and in-house specialty prescription formulations, resulting in higher profitability and stronger brand positioning. - The company is registered as a public limited entity and holds a valid GST license. - The company is registered in Indore, and we have our manufacturing unit in Dewas.

The company is a certified pharmaceutical formulations manufacturing company, specializing in tablets, capsules (soft and hard gelatin), liquid orals (syrups), and ointments. - Our primary business model is B2B, supplying to 50 stockists and 30 retailers. - The company holds multiple certifications and regulatory approvals, including WHO GMP (Good Manufacturing Practices), ISO 9001:2015 – Quality Management System, FSSAI (Food Safety and Standards Authority of India), CDSCO (Central Drugs Standard Control Organization), Ayush license, and State FDA approval. - Production capacity and utilization: 1) Tablets: Installed capacity – 1.03 crore units; current utilization – 30 to 80 lakh units. 2) Soft gelatin capsules: Installed capacity – 25 lakh units; utilization – 25 lakh units. 3) Hard gelatin capsules: Installed capacity – 15 lakh units; utilization – 9 lakh units. 4) Syrups (liquid orals): Installed capacity – 75,000 units; utilization – 13,000 units. 5) Ointments: Installed capacity – 5,000 tubes; utilization – 3,000 tubes. - Sales have significantly increased this year due to a strategic shift from generic drugs to ethical marketing and in-house specialty prescription formulations, resulting in higher profitability and stronger brand positioning. - The company is registered as a public limited entity and holds a valid GST license. - The company is registered in Indore, and we have our manufacturing unit in Dewas.